CervoMed Inc
cervomed.comWhat Do They Do?
Develops an investigational drug for dementia with Lewy bodies and other age-related brain disorders.
10-K for FY2025, filed Mar 13, 2026We are a clinical-stage biotechnology company developing treatments for age-related brain disorders. Our lead drug candidate, neflamapimod…View ↗
How Do They Make Money?
Government grants reimburse allowable costs for funded research projects; the NIA grant is paid in installments, and grant revenue is earned as qualifying costs are incurred.
10-K for FY2025, filed Mar 13, 2026The Company generates revenue from government contracts that reimburse the Company for certain allowable costs for funded projects.View ↗
The Company recognizes funding received from the NIA Grant as grant revenue, rather than as a reduction of research and development…View ↗
To date, we have not generated any revenue from product sales and we do not expect to do so in the near future. In January 2023, we were…View ↗
$4M
-
10-K for FY2025, filed Mar 13, 2026
$4M ↗
Who Are Their Customers?
Government agencies fund research through grants that reimburse allowable costs on funded projects.
10-K for FY2025, filed Mar 13, 2026
Do Revenues Turn Into Profits?
No. It lost $27M in FY2025.
10-K for FY2025, filed Mar 13, 2026
How Are They Changing?
From oxygen delivery to brain disorders
The older report focused on TSC, a candidate intended to improve oxygen delivery, while the latest centers on neflamapimod for age-related brain disorders.
10-K for FY2022, filed Mar 24, 2023 10-K for FY2025, filed Mar 13, 2026We are a clinical-stage biotechnology company developing treatments for age-related brain disorders. Our lead drug candidate, neflamapimod…View ↗
Who Do They Compete With?
Competes with Cognition Therapeutics
10-K for FY2025, filed Mar 13, 2026While there are numerous companies pursuing AD disease modifying approaches, we believe there are a limited number of companies in…View ↗
Loading...
